Ponatinib Market Report

Europe Ponatinib Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 24, 2020
  • PAGES：215
  • REPORT CODE：GMM484093
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Ponatinib market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Ponatinib Market Segmentations:

    By Player:

    • ARIAD Pharmaceuticals

    By Type:

    • 45mg

    • 15mg

    By End-User:

    • CML

    • ALL

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Ponatinib Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Ponatinib Market Size and Growth Rate of 45mg from 2014 to 2026

    • 1.3.2 Europe Ponatinib Market Size and Growth Rate of 15mg from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Ponatinib Market Size and Growth Rate of CML from 2014 to 2026

    • 1.4.2 Europe Ponatinib Market Size and Growth Rate of ALL from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Ponatinib Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Ponatinib by Major Types

      • 3.4.1 Market Size and Growth Rate of 45mg

      • 3.4.2 Market Size and Growth Rate of 15mg

    4 Segmentation of Ponatinib Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Ponatinib by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Ponatinib for CML

      • 4.4.2 Market Size and Growth Rate of Ponatinib for ALL

    5 Market Analysis by Major Regions

    • 5.1 Europe Ponatinib Production Analysis by Top Regions

    • 5.2 Europe Ponatinib Consumption Analysis by Top Regions

    • 5.3 Europe Ponatinib Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.3 France Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Production, Import, Consumption and Export Analysis

    6 Product Circulation of Ponatinib Market among Top Countries

    • 6.1 Top 5 Export Countries in Ponatinib Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Ponatinib Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Ponatinib Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Ponatinib Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Ponatinib Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Ponatinib Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Ponatinib Landscape Analysis

    • 7.1 Germany Ponatinib Landscape Analysis by Major Types

    • 7.2 Germany Ponatinib Landscape Analysis by Major End-Users

    8. UK Ponatinib Landscape Analysis

    • 8.1 UK Ponatinib Landscape Analysis by Major Types

    • 8.2 UK Ponatinib Landscape Analysis by Major End-Users

    9. France Ponatinib Landscape Analysis

    • 9.1 France Ponatinib Landscape Analysis by Major Types

    • 9.2 France Ponatinib Landscape Analysis by Major End-Users

    10. Italy Ponatinib Landscape Analysis

    • 10.1 Italy Ponatinib Landscape Analysis by Major Types

    • 10.2 Italy Ponatinib Landscape Analysis by Major End-Users

    11. Spain Ponatinib Landscape Analysis

    • 11.1 Spain Ponatinib Landscape Analysis by Major Types

    • 11.2 Spain Ponatinib Landscape Analysis by Major End-Users

    12. Poland Ponatinib Landscape Analysis

    • 12.1 Poland Ponatinib Landscape Analysis by Major Types

    • 12.2 Poland Ponatinib Landscape Analysis by Major End-Users

    13. Russia Ponatinib Landscape Analysis

    • 13.1 Russia Ponatinib Landscape Analysis by Major Types

    • 13.2 Russia Ponatinib Landscape Analysis by Major End-Users

    14. Switzerland Ponatinib Landscape Analysis

    • 14.1 Switzerland Ponatinib Landscape Analysis by Major Types

    • 14.2 Switzerland Ponatinib Landscape Analysis by Major End-Users

    15. Turkey Ponatinib Landscape Analysis

    • 15.1 Turkey Ponatinib Landscape Analysis by Major Types

    • 15.2 Turkey Ponatinib Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Landscape Analysis by Top Countries

      • 16.3.1 Denmark Ponatinib Market Volume and Growth Rate

      • 16.3.2 Finland Ponatinib Market Volume and Growth Rate

      • 16.3.3 Norway Ponatinib Market Volume and Growth Rate

      • 16.3.4 Sweden Ponatinib Market Volume and Growth Rate

      • 16.3.6 Iceland Ponatinib Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Landscape Analysis by Top Countries

      • 17.3.1 Belgium Ponatinib Market Volume and Growth Rate

      • 17.3.2 Netherlands Ponatinib Market Volume and Growth Rate

      • 17.3.3 Luxembourg Ponatinib Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Landscape Analysis by Top Countries

      • 18.3.1 Estonia Ponatinib Market Volume and Growth Rate

      • 18.3.2 Latvia Ponatinib Market Volume and Growth Rate

      • 18.3.3 Lithuania Ponatinib Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 ARIAD Pharmaceuticals

      • 19.1.1 ARIAD Pharmaceuticals Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    The List of Tables and Figures (Totals 110 Figures and 149 Tables)

    • Figure Product Picture

    • Figure Europe Ponatinib Market Size and Growth Rate of 45mg from 2014 to 2026

    • Figure Europe Ponatinib Market Size and Growth Rate of 15mg from 2014 to 2026

    • Figure Europe Ponatinib Market Size and Growth Rate of CML from 2014 to 2026

    • Figure Europe Ponatinib Market Size and Growth Rate of ALL from 2014 to 2026

    • Figure Germany Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure UK Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure France Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Ponatinib Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Ponatinib Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Ponatinib

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Ponatinib by Different Types from 2014 to 2026

    • Table Consumption Share of Ponatinib by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of 45mg

    • Figure Market Size and Growth Rate of 15mg

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Ponatinib by Different End-Users from 2014 to 2026

    • Table Consumption Share of Ponatinib by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of CML

    • Figure Market Size and Growth Rate of ALL

    • Table Europe Ponatinib Production by Major Regions

    • Table Europe Ponatinib Production Share by Major Regions

    • Figure Europe Ponatinib Production Share by Major Countries and Regions in 2014

    • Table Europe Ponatinib Consumption by Major Regions

    • Table Europe Ponatinib Consumption Share by Major Regions

    • Table Germany Ponatinib Production, Import, Consumption and Export Analysis

    • Table UK Ponatinib Production, Import, Consumption and Export Analysis

    • Table France Ponatinib Production, Import, Consumption and Export Analysis

    • Table Italy Ponatinib Production, Import, Consumption and Export Analysis

    • Table Spain Ponatinib Production, Import, Consumption and Export Analysis

    • Table Poland Ponatinib Production, Import, Consumption and Export Analysis

    • Table Russia Ponatinib Production, Import, Consumption and Export Analysis

    • Table Switzerland Ponatinib Production, Import, Consumption and Export Analysis

    • Table Turkey Ponatinib Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Ponatinib Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Ponatinib Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Ponatinib Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Ponatinib Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Ponatinib Consumption by Types from 2014 to 2026

    • Table Germany Ponatinib Consumption Share by Types from 2014 to 2026

    • Table Germany Ponatinib Consumption by End-Users from 2014 to 2026

    • Table Germany Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table UK Ponatinib Consumption by Types from 2014 to 2026

    • Table UK Ponatinib Consumption Share by Types from 2014 to 2026

    • Table UK Ponatinib Consumption by End-Users from 2014 to 2026

    • Table UK Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table France Ponatinib Consumption by Types from 2014 to 2026

    • Table France Ponatinib Consumption Share by Types from 2014 to 2026

    • Table France Ponatinib Consumption by End-Users from 2014 to 2026

    • Table France Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table Italy Ponatinib Consumption by Types from 2014 to 2026

    • Table Italy Ponatinib Consumption Share by Types from 2014 to 2026

    • Table Italy Ponatinib Consumption by End-Users from 2014 to 2026

    • Table Italy Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table Spain Ponatinib Consumption by Types from 2014 to 2026

    • Table Spain Ponatinib Consumption Share by Types from 2014 to 2026

    • Table Spain Ponatinib Consumption by End-Users from 2014 to 2026

    • Table Spain Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table Poland Ponatinib Consumption by Types from 2014 to 2026

    • Table Poland Ponatinib Consumption Share by Types from 2014 to 2026

    • Table Poland Ponatinib Consumption by End-Users from 2014 to 2026

    • Table Poland Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table Russia Ponatinib Consumption by Types from 2014 to 2026

    • Table Russia Ponatinib Consumption Share by Types from 2014 to 2026

    • Table Russia Ponatinib Consumption by End-Users from 2014 to 2026

    • Table Russia Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Ponatinib Consumption by Types from 2014 to 2026

    • Table Switzerland Ponatinib Consumption Share by Types from 2014 to 2026

    • Table Switzerland Ponatinib Consumption by End-Users from 2014 to 2026

    • Table Switzerland Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Ponatinib Consumption by Types from 2014 to 2026

    • Table Turkey Ponatinib Consumption Share by Types from 2014 to 2026

    • Table Turkey Ponatinib Consumption by End-Users from 2014 to 2026

    • Table Turkey Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Ponatinib Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Ponatinib Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Ponatinib Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Ponatinib Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of ARIAD Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ARIAD Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of ARIAD Pharmaceuticals

    • Figure Revenue and Market Share Analysis of ARIAD Pharmaceuticals

    • Table Product and Service Introduction of ARIAD Pharmaceuticals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US